Výsledky vyhledávání - "Peixoto da Silva S"

Akademický článek

Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells.

Autor: Matos BS; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal., Peixoto da Silva S; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Department of Biological Sciences, FFUP - Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, Porto 4050-313, Portugal., Vasconcelos MH; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Department of Biological Sciences, FFUP - Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, Porto 4050-313, Portugal., Xavier CPR; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; UCIBIO - Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), Gandra 4585-116, Portugal.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, University Institute of Health Sciences - CESPU, Gandra 4585-116, Portugal.

Publikováno v: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2024 May 20; Vol. 7, pp. 19. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia.

Autor: Peixoto da Silva S; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal., Santos JMO; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal., Mestre VF; Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal., Medeiros-Fonseca B; Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal., Oliveira PA; Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal., M S M Bastos M; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal., Gil da Costa RM; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal.; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.; Postgraduate Programme in Adult Health (PPGSAD), Tumour and DNA Biobank, Federal University of Maranhão (UFMA), 65080-805 São Luís, Brazil., Medeiros R; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal.; Virology Service, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; CEBIMED, Faculty of Health Sciences of the Fernando Pessoa University, 4249-004 Porto, Portugal.; Research Department of the Portuguese League Against Cancer-Regional Nucleus of the North (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte), 4200-177 Porto, Portugal.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2020 Jul 16; Vol. 21 (14). Date of Electronic Publication: 2020 Jul 16.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The Emerging Role of MicroRNAs and Other Non-Coding RNAs in Cancer Cachexia.

Autor: Santos JMO; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal., Peixoto da Silva S; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal., Gil da Costa RM; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal.; Postgraduate Programme in Adult Health (PPGSAD), Tumour and DNA Biobank (BTMA), Federal University of Maranhão (UFMA), 65080-805 São Luís, Brazil.; Laboratory for Process Engineering, Environment, Biotechnology and Energy (LEPABE), Faculty of Engineering of the University of Porto (FEUP), 4200-465 Porto, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal.; Research Department of the Portuguese League Against Cancer-Regional Nucleus of the North (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte), 4200-177 Porto, Portugal.; Virology Service, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Biomedical Research Center (CEBIMED), Faculty of Health Sciences of the Fernando Pessoa University, 4249-004 Porto, Portugal.

Publikováno v: Cancers [Cancers (Basel)] 2020 Apr 19; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 19.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The Role of MicroRNAs in the Metastatic Process of High-Risk HPV-Induced Cancers.

Autor: Santos JMO; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal. joana.oliveira.santos@ipoporto.min-saude.pt.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal. joana.oliveira.santos@ipoporto.min-saude.pt.; Research Department of the Portuguese League Against Cancer⁻Regional Nucleus of the North (Liga Portuguesa Contra o Cancro⁻Núcleo Regional do Norte), 4200-177 Porto, Portugal. joana.oliveira.santos@ipoporto.min-saude.pt., Peixoto da Silva S; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal. peixotodasilva.sara@gmail.com.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal. peixotodasilva.sara@gmail.com., Costa NR; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal. maria.vieira.costa@ipoporto.min-saude.pt., Gil da Costa RM; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal. rmcosta@fe.up.pt.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal. rmcosta@fe.up.pt., Medeiros R; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Research Department of the Portuguese League Against Cancer⁻Regional Nucleus of the North (Liga Portuguesa Contra o Cancro⁻Núcleo Regional do Norte), 4200-177 Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Virology Service, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Biomedical Research Center (CEBIMED), Faculty of Health Sciences of the Fernando Pessoa University, 4249-004 Porto, Portugal. ruimedei@ipoporto.min-saude.pt.

Publikováno v: Cancers [Cancers (Basel)] 2018 Dec 05; Vol. 10 (12). Date of Electronic Publication: 2018 Dec 05.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání